245 related articles for article (PubMed ID: 27246933)
1. Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a quality improvement audit.
Vijay A; Grover A; Coulson TG; Myles PS
Anaesth Intensive Care; 2016 May; 44(3):346-52. PubMed ID: 27246933
[TBL] [Abstract][Full Text] [Related]
2. Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.
Roshanov PS; Rochwerg B; Patel A; Salehian O; Duceppe E; Belley-Côté EP; Guyatt GH; Sessler DI; Le Manach Y; Borges FK; Tandon V; Worster A; Thompson A; Koshy M; Devereaux B; Spencer FA; Sanders RD; Sloan EN; Morley EE; Paul J; Raymer KE; Punthakee Z; Devereaux PJ
Anesthesiology; 2017 Jan; 126(1):16-27. PubMed ID: 27775997
[TBL] [Abstract][Full Text] [Related]
3. Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: a multicentre, prospective cohort study.
STARSurg Collaborative
Anaesthesia; 2018 Oct; 73(10):1214-1222. PubMed ID: 29984818
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.
Hollmann C; Fernandes NL; Biccard BM
Anesth Analg; 2018 Sep; 127(3):678-687. PubMed ID: 29381513
[TBL] [Abstract][Full Text] [Related]
5. Effect of continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on the day of surgery on myocardial injury after non-cardiac surgery: A retrospective cohort study.
Kim J; Lee S; Choi J; Ryu DK; Woo S; Park M
J Clin Anesth; 2024 Jun; 94():111401. PubMed ID: 38330844
[TBL] [Abstract][Full Text] [Related]
6. Perioperative use of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists.
Vaquero Roncero LM; Sánchez Poveda D; Valdunciel García JJ; Sánchez Barrado ME; Calvo Vecino JM
J Clin Anesth; 2017 Aug; 40():91-98. PubMed ID: 28625460
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin axis blockade, acute kidney injury, and perioperative morbidity in patients undergoing colorectal surgery: A retrospective cohort study.
Bonavia A; Javaherian M; Skojec AJ; Chinchilli VM; Mets B; Karamchandani K
Medicine (Baltimore); 2019 Aug; 98(33):e16872. PubMed ID: 31415426
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
Steely AM; Callas PW; Bertges DJ;
J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study.
Roberts DJ; Smith SA; Tan Z; Dixon E; Datta I; Devrome A; Hemmelgarn BR; Tonelli M; Pannu N; James MT
J Surg Res; 2021 Jul; 263():34-43. PubMed ID: 33631376
[TBL] [Abstract][Full Text] [Related]
10. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.
Coca SG; Garg AX; Swaminathan M; Garwood S; Hong K; Thiessen-Philbrook H; Passik C; Koyner JL; Parikh CR;
Nephrol Dial Transplant; 2013 Nov; 28(11):2787-99. PubMed ID: 24081864
[TBL] [Abstract][Full Text] [Related]
11. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
[TBL] [Abstract][Full Text] [Related]
12. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
[TBL] [Abstract][Full Text] [Related]
13. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
14. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
15. Continuation of Angiotensin-Converting Enzyme Inhibitors on the Day of Surgery Is Not Associated With Increased Risk of Hypotension Upon Induction of General Anesthesia in Elective Noncardiac Surgeries.
Yoon U; Setren A; Chen A; Nguyen T; Torjman M; Kennedy T
J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):508-513. PubMed ID: 32029371
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Coleman CI; Makanji S; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
[TBL] [Abstract][Full Text] [Related]
17. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.
White CM; Kluger J; Lertsburapa K; Faheem O; Coleman CI
Eur J Cardiothorac Surg; 2007 May; 31(5):817-20. PubMed ID: 17350856
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery.
Nielson E; Hennrikus E; Lehman E; Mets B
J Hosp Med; 2014 May; 9(5):283-8. PubMed ID: 24464761
[TBL] [Abstract][Full Text] [Related]
19. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Type 1 Cardiorenal Syndrome.
Ilges DT; Dermody ML; Blankenship C; Mansfield V; Van Tuyl JS
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):611-618. PubMed ID: 34138673
[TBL] [Abstract][Full Text] [Related]
20. Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments.
Hirai T; Yamaga R; Fujita A; Itoh T
J Clin Pharm Ther; 2018 Dec; 43(6):829-835. PubMed ID: 29908131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
